Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





Unique Competition Focuses on Using Data Science to Forecast Preanalytical Errors

By LabMedica International staff writers
Posted on 27 Jul 2023

Many institutions grapple with the issue of excess hemolyzed samples and are keen to understand how to address this problem while preserving scarce resources. The AACC session titled "Data Analytics Competition: Forecasting Future Preanalytical Errors" focused on this very issue.

At the session, Mark Zaydman, MD, Ph.D., from Washington University in St. Louis (WUSTL, St. Louis, MO, USA) announced the winners of a unique competition focused on utilizing data science to predict preanalytical errors arising from incorrect blood specimen collection. The session highlighted the lessons that medical lab professionals could learn from this competition. Co-hosted by the Section of Pathology Informatics of Washington University in St. Louis and the ADLM Data Analytics Steering Committee, the competition used a machine-learning and data-science platform called Kaggle to crowdsource solutions for problems across disciplines.

The competition for this year, titled "Help with Hemolysis," provided a real-world, anonymized dataset reflecting hemolysis within the clinical lab. Contestants had to use this dataset to determine which blood-specimen collectors could gain the most from training in phlebotomy best practices. The idea was to discover ways to reduce in vitro hemolysis while effectively using laboratory time and resources. The winning solution could guide institutions on how to better allocate their training resources. While educational interventions can help reduce hemolysis, they can be expensive and temporary, especially with a high staff turnover. A total of 18 participating teams had slightly over a month to work with the provided dataset before submitting their solution and also had to submit their code to demonstrate their problem-solving approach.

After providing an overview of the competition and summarizing the strategies adopted by the teams, Zaydman announced the winning team—Team Hemolyers. The winning team then shared their solution, offering attendees the opportunity to learn more about them, their approach to the problem, and ask any questions. The session's innovative teaching style differed from the conventional lecture format, aiming to cater to individuals of varying levels of experience. The format of the competition, which is into its second year, provided a novel way to learn, foster a collaborative community, and discover powerful solutions for real-world problems. Zaydman who had hosted the first competition as well pointed out that interdisciplinary teams—combining clinical lab expertise and computer-science knowledge—had been the winners both the times. This was mainly attributed to the increasing accessibility of data science tools and computational resources to individuals without advanced data science degrees. Such interdisciplinary teams can identify gaps in patient care and collaborate to develop innovative and viable solutions.

Despite the particular difficulty of the task for this year's competition, Zaydman stressed that the results were remarkable. “A valuable model doesn’t have to be perfect, as long as it saves costs and improves patient care,” he said.

Related Links:
WUSTL

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Hemoglobin/Haptoglobin Assay
IDK Hemoglobin/Haptoglobin Complex ELISA
New
Luteinizing Hormone Assay
DRG LH-Serum ELISA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.